chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Two days after receiving flu shot I couldn't move my right shoulder and upper arm. 3 months later I'm still having problems. The pain is getting a bit better but still do not have full mobility.
a "little bit" of headache; This is a spontaneous report from a Pfizer Sponsored program, received from a non-contactable consumer reporting for herself. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) , via an unspecified route of administration on 21Jan2021 as a SINGLE DOSE for COVID-19 vaccination.  The patient's medical history included migraines from an unknown date and unknown if ongoing.  The patient's concomitant medications were not reported.  On 21Jan2021, the patient experienced a "little bit" of headache, but it is nothing unusual to her since she has always had migraines in the past. She said apart from that, she is not experiencing any side effects as of the moment. If in case she experiences any more headaches, she wants to know if it would be okay to take ibuprofen (ADVIL), Ibuprofen or acetaminophen (TYLENOL) to treat it. The clinical outcome of a "little bit" of headache was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
24 hours after vaccine I started feeling body aches, fever of 102.2 and chills.  I went to bed and next day I had a sore throat, joint pain, body aches and slept all day.  Fever lasted 18 hour (went down to 99.8 by morning).  Symptoms lasted 36 hours.  Was fine after that.
Fever of 103 on Friday and Saturday evening May 20-21, Complained of body aches. Child came to clinic on Monday 05/23/2016 complaining of sore throat and blisters on lips. Follow up visit today no fever times 24 hours with less throat pain. She has new crust covered lesions to lower lip and fine papules to tongue. Itching and pustular with some discomfort. KEFLEX given today 05/25/16.
Was given the monovalent Pfizer for ages 5-11 as a booster prior to the bivalent becoming available, but was given the dose 3 months after completing the initial series instead of at 5 months after completing as was approved in the EAU. Parent notified on 11/01/2022 and reports no adverse reactions to the vaccination.  CDC also notified on 11/01/2022 and informed staff that no further action is needed at this time.
Patient was given the 4mo dose of Vaxelis and parent called in the next day and reported the patient had 104 degree fever.; This non-serious spontaneous safety report was received by a partner on 09-DEC-2021 and forwarded to Agency on 10-DEC-2021 from a healthcare professional .  The reporter did not provide an assessment of the causal relationship between Vaxelis and the reported event of patient was given the "4mo dose of Vaxelis" and the next day the patient had 104 degree fever.  No further information is expected.
Information regarding Flumist nasal solution was received from a consumer regarding a female patient who experienced runny nose, dry cough, achy muscles, and low grade fever. The patient received the vaccine. The patient's concurrent illnesses include mild egg allergy and autoimmune thyroiditis. Indication for Flumist was immunization. Product was administered on an unspecified date. Dose regimen was not provided. Concomitant medications were not reported. The patient experienced runny nose immediately after vaccination. Four days post-immunization, she developed a dry, deep cough. Five days post-immunization, she experienced achy muscles. Six days post-immunization, she developed a low grade fever. The reporter indicated that she participated in a Flumist study in 1998 and had none of these side effects. No additional information was available at the time of this report.
Pt received 1st moderna vaccine on 3/15/2021 and was admitted with sudden hypoxia , sob , low grade fever and pleuritic chest pain  10 days later.  Pt is lifelong non smoker. no recent travel or recent illness. no new medications.
Large (double the size of a half dollar) red ring with bullseye in the center. Hot to the touch and very swollen. She is extremely sore and is limping. She had her shots yesterday where she was given 3 and this morning work up do large red spot and continued to double in size.
A sore throat started after vaccine. By 1/23 could hardly get out of bed; hips, groin, shoulder, neck in excruciating soreness and pain. Started taking ibuprofen which helped a little. On 2/24 had doctor visit and got prednisone for 6 days. After prednisone done had 5 more days of pain relief. 75% of pain is back. Pain at a 7. Difficulty getting up and down or put on socks. Will go back to doctor soon.
Pain in muscle where injected when touched or used for 3 days I couldn't use my arm. The 3rd day the pain began to lessen but the skin on all the back of my arm was red and itchy. By the 5th day all pain gone but still itches some. In the first of nights the pain woke me up many times.
pt recv vax in summer of 1989 & approx 15min p/vax pt exp severe h/a, flushing sensation, pale skin, weakness, diaphoresis, lightheadedness;exp abd cramps, mild tachycardia & elevated BP;also fatigue, little appetite & cough;
Large, 3 inch diameter area of induration and erythema, warm and tender to touch. Symptoms still present after 3 days.
headache; soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (soreness) and HEADACHE (headache) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced PAIN (soreness). On 28-Apr-2021, the patient experienced HEADACHE (headache). At the time of the report, PAIN (soreness) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. Patient wanted to know whether she can take naproxen after the vaccine.
ROTATEQ, PEDV AX HIB, RECOMBIV AX HB, GARDASIL 9 and VAQTA that went out of range were potentially administered; No additional adverse effect reported; Information has been received from a nurse istant and refers to a patient of unknown age and gender. There was no information about patient's concurrent conditions, medical history, concomitant medications or drug reactions/allergies.  On unknown dates, the patient was potentially vaccinated with doses of the following vaccines that were out of range: hepatitis b vaccine (recombinant)(RECOMBIVAX HB), lot # R028529 and expiration date of 09-JUN-2021, lot # T004378 and expiration date of 01-NOV-2022 and lot # R021372 and expiration date of 25-MAY-2021, hepatitis a vaccine, inactivated(VAQTA) lot # T020442 and expiration date of 26-JAN-2022 and lot # T014835 and expiration date of 17-JUL-2021, haemophilus b conjugate vaccine (meningococcal protein conjugate)(LIQUID PEDVAXHIB) lot # T001208 and expiration date of 09-JUN-2022 and lot # T020615 and expiration date of 13-MAR-2023, hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) lot number 1621926 and expiration date of 28-NOV-2021 and lot # 1602284 and expiration date of 26-SEP-2021 (route of administration and anatomical location were not reported) and with rotavirus vaccine, live, oral, pentavalent(ROTATEQ) lot # 1676322 and expiration date of 21-APR-2021, lot # 1688822 and expiration date of 20-NOV-2021 and lot # 1691301 and expiration date of 12-DEC-2021 per oral route, all for prophylaxis, which were stored in the following ranges: 9 Celsius degrees to 25 Celsius degrees (8.53 Celsius degrees) for 15 minutes and 9 Celsius degrees to 25 Celsius degrees (11.6 Celsius degrees) for 45 minutes.  No previous temperature excursion was reported. No additional adverse effects were reported.  Digital data logger was involved.  This is one of several reports from the same reporter. ; Sender's Comments:  US-009507513-2103USA003717: US-009507513-2103USA005236: US-009507513-2103USA005237: US-009507513-2103USA005238: US-009507513-2103USA005239: US-009507513-2103USA005240: US-009507513-2103USA005241: US-009507513-2103USA005234: US-009507513-2103USA005233:
Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/26/21 and 3/19/21. Previously admitted in 12/2021 for K. pneumoniae septicemia d/c'd. Tested Covid+ 1/10/22 at facility. Transferred from facility and admitted 1/21/22 altered mental status with acute encephalopathy and pos Covid test again. CXR with patchy bilateral opacities. Placed on bipap, AMS never improved. Unable to eat 2/2 AMS, placed on PPN. Hospital course c/b AFib in RVR, started on amiodarone gtt. Treated with dexamethasone, actemra, and baricitinib. Transitioned to DNAR, expired 2/3/22. Pt transitioned to DNAR. Patient expired 2/3/22.
After laying down on the dog's bed patient developed uticaria on his shoulders and arms and developed facial and lip swelling.  He was seen at the office and given Benadryl 37.5mg po X1 and was observed for 45 minutes.  He was noted to have a decrease in swelling and his hives had faded.  No respiratory distress was noted.  Patient was d/c home with an RX for Epi-pen and advised to start Claritin qHS.
Rash appear on their face; This case was reported by a pharmacist via call center representative and described the occurrence of rash in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced rash. On an unknown date, the outcome of the rash was unknown.   It was unknown if the reporter considered the rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient experienced a rash on the face after receiving Shingrix. The reporter did not consent to follow-up. The reporter had no additional details about the patient or the vaccine.
I have been experiencing some itching like yesterday it was like really tuff and hard, really like toff, sore and hard/had some you know like soreness; Swelling; A knot in my arm; Itchy; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: not reported; Expiry date: unknown), via an unspecified route of administration, administered in Arm Right on 14Jun2021 as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced "I have been experiencing some itching like yesterday it was like really tuff and hard, really like toff, sore and hard/had some you know like soreness" on 20Jun2021, swelling, a knot in my arm and itchy in Jun2021. It was reported that patient was calling because she/he had the vaccine done on the Monday of last week and have been experiencing some itching like yesterday it was like really tuff and hard, really like toff , sore and hard, is that like known symptom that been you know kind a talked about recently or something. The patient had very itchy and swelling, some soreness but soreness is gone, and it just itchy very itchy like a knot in arm. Reporter seriousness for the events was provided as unspecified. The clinical outcome of the event pain was recovered on unspecified date in Jun2021; for swelling, mass and pruritus was unknown.  Information on lot/batch number has been requested.
Abdominal Pains/Cramps (S), Fainting Spells (D), Muscle Spasms (S), Acid-Reflux (D), Fatigue (D), Muscle Weakness (D), Adult-Onset Stills Disease (S), Fertility Problems (D), Myofascial Pain Syndrome (D), Allergies (D), Fever (S), ALS (S), Fibromyalgia (S), Neck Pain (D), Anaphylaxis Shock (D), Flu-Like Symptoms (S), Anxiety (D), Fluid Build-Up (D), ELEVATED (INTRACRANIAL) PRESSURE (D), Numbness/Tingling in Extremities (D), Aplastic Anemia (S), Gastrointestinal Disorders (D), Arthritis/Rheumatoid Arthritis (D), GERD (S), Optic Neuritis (S), Asthma(S), Graves Disease (S), Autoimmune Disorder (S), Gray-Outs (D), Panic Attacks (D), Back Pain (D) (lower), Guillain-Barre Syndrome (S), Paralysis (ALL 4 LIMBS AT TIMES) (D), Bells Palsy (S), Gynecological Disorders (D), Paresthia (D), Heart Attack (S), Peripheral neuropathy (S), Black-Outs (D), Heart Disease (D), Blindness/Renal Failure (S), Heart Lesions (LAD MYOCARDIAL BRIDGE) (D), Psoriasis (S), Blisters (S) (INNER THIGHS) COMES AND GOES (D), Blood Clots (S), High Blood Pressure (D), Rash (D), Blood Disorder (D), Hip Pain (S), Blood/Mucus in Stool (S), Hives (D), Blood Pressure Spikes (D), Hot Flashes (S), Body Aches (S), Hypertension (D), Required (s) Breathing Apparatus (D), (OBSTRUCTIVE SLEEP APNEA), Brain Damage (S), Insomnia (D), Respiratory Problems (D), Cancer (S) (Testicular), Carpal Tunnel (S), Irritability (S), Ringing in the Ear (S), Chills (S), Joint Pain (S), Seizure Disorder (S), Chronic Cough (S), Sexual Malfunctions (D), Chronic Fatigue (D), Shortness of Breath (D), Chronic Pain (D), Light Sensitivity (S), Sinus Problems (D), Cognitive Problems (S), Liver Damage (S), Colitis (D), Loss Sense of Direction (S), Skin Sensitivity(D), Concentration Problems (D), Loss Sense of Time (S), Sleep Apnea(D), Dehydration (S), Constipation (S), Sleeping Problems (D), Crohn's Disease (S), Cysts (Testes) (D), Lung Disease (D) (COPD changes), Stroke (S), Depression (D), Malaise (D), Sweating Problems (S), Diabetes (S), Memory Loss (D), Swelling in Extremities (D), Diarrhea (S), Swollen Glands (D), Digestive Problems (S), Migraines/Headaches(D), Testicular Problems (D), Disorientation (S), Testosterone Problems(D), DVT (S), Mood Disturbances (D), Thyroid Disease (S), Eczema (D), Tightness/Pain in Chest (D), Extremity Failure (D), (arms/legs) Muscle Pain (D), Tremors (S), Vertigo (D), Weakened Immune System (D), Vision Problems (D) (BLURRED, tunnel), Weight Gain & loss my weight fluctuates approx 15 lbs every 2wks.   4/27/06 Review of medical records for date range 7/20/04 to 5/2/05. Operative report of 7/20/04 indicates pre-op diagnosis of L orchialgia, post-op diagnosis of L orchialgia, L hydrocele, and L varicocele. Surgery done was L varicocelectomy, L hydrocelectomy, and L spermatic cord denervation. On 9/7/04 patient had placement of bilateral testicular prostheses. Pre- and post-operative diagnosis was anorchia. On 9/16/04 the L prosthesis was removed due to pain. On 5/2/05 the patient presented to ER with chest pain. Diagnosis stated as acute coronary syndrome. He had a positive stress test (chest pain & dyspnea) on 4/28/05 and pain was identical to that on ER admission.
Patient received monkeypox vaccine on 7/22/22. Developed subjective fevers, weakness, followed by a rash 24 hours later, diffuse, pruritic on 7/25.  Previous sexual encounter 1 month prior to vaccination. Diagnosed with monkeypox.
patient started tingling all over within a few minutes of getting her shot. She stayed that way for about 25 minutes and then it resolved to just her lips. She walked away and within 2 minutes her throat closed up and she came back saying she could not breath or swallow. We called 911 and administered epinephrine right away. A second dose was given when we got no improvement 15 minutes later. She was also given Benadryl 25mg liquid because she could not swallow pills. EMS arrived about 11:35am and she was taken to the hospital. She reports feeling much better this morning and just being achy all over.
Urticarial rash, started on lower extremities, bilateral anterior thighs, spread to groin region, then to face, ears, upper chest and then upper extremities, also on face and neck with left pinna markedly inflammed. Started with rash in the evening on 11/1/00.
Patient reports breaking out with rash on left upper arm and lower and upper back after 1st dose of HPV vaccine. Patient reported this on 3/9/16 when she came in for second vaccine dose.
Tested positive for COVID about six weeks after receiving the Moderna booster. Symptoms, fortunately, were relatively mild.
1st dose January 27. Patient test positive February/ patient tested positive for covid last Feb 2; This is a spontaneous report from a contactable pharmacist. A female patient of an unspecified age received first dose of bnt162b2 (PFIZER BIONTECH COVID-19 VACCINE, solution for injection, Lot number was not reported) via an unspecified route of administration on 27Jan2021 as single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient tested positive for Covid-19 on 02Feb2021, didn't get the 2nd dose since. The patient underwent lab tests and procedures which included sars-cov-2 test result was positive on 02Feb2021.The outcome of events unknown.  Information on the lot/batch number has been requested.  Follow-up (16-JUN-2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Started dry cough, to excess mucus throat, throat swelling, fluid filling  in upper chest, chest pain, sob, lasted approximately 5 min then symptoms went away one by one. Left after another 1 hour watch. Chest pressure and fatigue lasting 24 hours then 0 symptoms
Given H1N1 on 11/23/09. Patient's husband called today to report patient has had facial swelling since last week, denies other problems. Swelling eventually goes down but now getting worse. Referred to Emergency Room.
front of the tongue is sore; scratchy throat; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 26-Feb-2021 and was forwarded to Moderna on 28-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of GLOSSODYNIA (front of the tongue is sore) and OROPHARYNGEAL PAIN (scratchy throat) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M204) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced GLOSSODYNIA (front of the tongue is sore) and OROPHARYNGEAL PAIN (scratchy throat). At the time of the report, GLOSSODYNIA (front of the tongue is sore) and OROPHARYNGEAL PAIN (scratchy throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were reported No treatment medication were reported.
This spontaneous report as received from a Nurse Practitioner refers to an unknown number of patients were inadvertently vaccinated with GARDASIL, RECOMBIVAX HB, VAQTA, and PEDVAXHIB had been improperly stored. No further information was provided. Additional information was received from Nurse Practitioner, who reproted that GARDASIL, RECOMBIVAX HB, VAQTA, PEDVAXHIB, went through multiple unsupported temperature excursions from 10/09/2013 to 10/17/2013. The Nurse Practitioner reported that PEDVAXHIB (Lot# J005670, expiration 12/17/2015) was administered to 1 unspecified patient on 10/15/2013, 1 unspecified patient on 10/25/2013 (MARRS#1401USA000276) and 1 unspecified patient on 10/29/2013 (MARRS#1401USA000280). The Nurse Practitioner also reported GARDASIL (Lot#J003727, expiration date 11/07/2015) was administered to 3 unspecified patients on 10/25/13 (MARRS#1401USA000268) and 1 unspecified patient on 10/26/2013 (MARRS#1401USA00027_). VAQTA (Lot#J008090, expiration date 08/23/2105) was administered to 1 unspecified patient on 10/17/2013 (MARRS#1401USA000279) and 1 unspecified patient on 10/25/2013. RECOMBIVAX (Lot#H012250, expiration date 02/06/2015) was administered to 1 unspecified patient on 10/26/2013 (MARRS#1401USA000277). No adverse effects reported. No further information was provided. Additional information has been requested.
No additional adverse events; The patient was administered an improperly stored VARIVAX; This spontaneous report was received from a medical assistant regarding a patient of unknown age and gender. The patient's concurrent conditions, pertinent medical history, drug reactions, allergies, and concomitant therapies were not reported.    On 25-NOV-2019, the patient was vaccinated with improperly stored dose (product storage error) of varicella virus vaccine live (Oka/Merck) (VARIVAX) lot number R023736, expiration date 20-AUG-2020 for prophylaxis (dose and route of administration was not reported). The diluent that was used to reconstituted the vaccines was properly stored. There was no additional adverse effect reported. Administered dose of vaccine experienced the temperature excursion of -9 Celsius (°C)  to 8°C (0.9°C) degrees Celsius for 15 hours and 15 minutes. The previous excursions reported was -14°C to -10°C (-13.04 °C) for 45 minutes. Data logger was no involved.
local reaction to the site. Swelling, redness, and warm to touch. Patient came to pharmacy 8/20/19 to show reaction. Pharmacist advised patient to use ice packs for the swelling, ibuprofen for the pain and swelling, and benadryl at night.  Primary Dr. has been contacted and advised same course of action as the pharmacist
Continuous production of phlegm in the repiratory tract, particularly in the morning, but throughout the day,
On May 18, 1999, the pt received her first (IM-Left Deltoid) dose of Lymerix.  She experienced soreness at the injection site which resolved the next day. Approximately 4 days later, she experienced an injection site rash consisting of several hard red lumps which were warm and itched. Her symptoms resolved in 3-4 days.  On 6/18/99, the pt received her second (IM-Left Deltoid) dose of Lymerix.   Approximately 4 days later on 6/22/99, she experienced the same reaction with additionally a red area which measured 6 in x 3 in. No treatment was given.  The pt states that her symptoms resolved on 6/29/99.  The most recent information received on 7/7/99, reports the condition of the pt as resolved.
Received vaccine on 8/2/04. Child had hard knot about 4cm, redness quarter sized around knot at injection site. Child brought in next day around noon, examined by RN. Advised warm compresses observe. No other problems or fever noted.
Fevers to 101 degrees F, myalgia, and local pain at the site of injection.
7 th day after vaccination, arm site began itching about 6 pm. Gradually began stinging & sore by 11pm.  Worse the next morning [Friday 2/5j) developed a red spot size of a nickel, then grew larger over the morning with swelling around it, 4 inches across, ver sore!  Morning of 2/6 redness much larger, swelling around it worse.   Felt tired & kind of like I had mild case of flu too
04/14/2022 Vaccination 06/28/2022-07/14/2022 Traveled on vacation. 07/15/2022 I woke up feeling crummy. It was typical symptoms to body immune response. Headache, fatigue. At home antigen test POSITIVE. I called my doctor who prescribed Plaxovid.  07/20/2022 Feeling fine presently.
11/24 Pt to ED complaints of dark tarry stools. Per EMS, patient is also covid positive for the past week and has been tachycardic.  11/25 COVID-19 infection, tolerating very well. RA o2. GI Bleed. 11/27 No significant infiltrate noted on chest x-ray 11/30 Stable for transfer back to nursing home facility
Patient with vasovagal syncope. Rapidly improved with position change, hydration, and monitoring. Returned home with mother as the driver.
muscular-skeletal pain ongoing since vaccine, swelling of ankles, palpitations unexpectedly, weakness in legs and arms, tingling in feet
pt recvd vax 5PM started high pitched screaming & t102; legs both red, warm, swelling; taken to ER @ 8PM, t104 ear cont inc pitch screaming, legs red & swollen entire thigh; 3 groin & up back & waist;